New Imaging and Treatment Strategies in Rectal Cancer

Surgeons need to adapt to evolving diagnostic and treatment protocols for rectal cancer to enhance patient outcomes.

Mortality rates from rectal cancer are declining, driven by improved screening and staging.
Neoadjuvant radiochemotherapy can allow less invasive surgery for patients with non-advanced disease.

Incorporating imaging advancements can aid in personalized treatment strategies.

Abdominopelvic MRI and transrectal ultrasound are key for local staging, while CT and PET are essential for distant metastasis detection.

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

Ann Surg Oncol2 Nov 2026

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

JAMA Surg30 Oct 2026

For severe slow-transit constipation, removing less colon gave similar symptom relief at one year, with less early incontinence.

Surg Endosc29 Oct 2026

In low rectal cancer surgery, removing the specimen through the anus was linked to fewer wound complications and less pain in the first two days.